Blood-borne and Sexually Transmitted Infections: a Cross-sectional Study in a Swiss Prison

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2018 Oct 31

PMID 30373535

Citations 8

Authors

Komal Chacowry Pala

Stephanie Baggio

Nguyen Toan Tran

Francois Girardin

Hans Wolff

Laurent Getaz

Affiliations

Soon will be listed here.

Abstract

Background: Incarcerated people carry a high burden of infection, including blood-borne diseases (BBDs). It is also known that one million people contract a sexually transmitted infection (STI) every day worldwide, which represents a global public health challenge. However, data regarding the prevalence of STIs and the risk factors among incarcerated populations are lacking. The objective of this study was to determine the prevalence and associated factors of BBDs and STIs among detainees in the largest pre-trial prison in Switzerland.

Methods: In a cross-sectional study conducted at the Champ-Dollon pre-trial prison, 273 male detainees answered a standardized questionnaire and were screened for syphilis, herpes simplex virus 2 (HSV-2), HIV, and hepatitis C (HCV). Prevalence rates and associations of BBDs and STIs with risk factors were computed.

Results: Most participants (90.9%) were migrants from outside Western Europe, and 5.9% were injecting drug users. HCV was diagnosed among 6.2% of participants (antibody prevalence). The prevalence of HCV was higher among injecting drug users (81.2%) than non-injectors (1.6%). The prevalence of HIV, syphilis, and HSV-2 was 0.4%, 1.1%, and 22.4%, respectively. HCV was associated with a history of injecting drug use and HSV-2 with a lower education level and being older than 26 years.

Conclusions: This study showed the infection prevalence of 2-9 times higher among detainees than in the Swiss community. It also illustrated that these infections are associated with sociodemographic and risk factors. Therefore, the prison environment offers an opportunity to strengthen infectious disease control programs targeting specific subgroups of at-risk people. Such programs would benefit both the prison population and broader society.

Citing Articles

Examining risk factors for HIV infection amongst male inmates in Peruvian prisons: a cross-sectional study using national prisoner census data.

Quispe-Canari J, Carrasco-Navarro R Rev Esp Sanid Penit. 2025; 26(3):82-91.

PMID: 39927805 PMC: 11632554. DOI: 10.18176/resp.00093.

Improving implementation of needle and syringe programmes to expand, scale up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons.

Kronfli N, Bromberg D, Wolff H, Montanari L, Vasyliev S, Altice F Lancet Public Health. 2024; 10(1):e63-e70.

PMID: 39701113 PMC: 11823114. DOI: 10.1016/S2468-2667(24)00275-5.

HBV in Italian Women's Jail: An Underestimated Problem?.

Geremia N, Giovagnorio F, De Vito A, Martignago L, Fiore V, Rastrelli E J Clin Med. 2024; 13(5).

PMID: 38592679 PMC: 10932425. DOI: 10.3390/jcm13051398.

Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis.

Busschots D, Kremer C, Bielen R, Koc O, Heyens L, Nevens F BMC Public Health. 2022; 22(1):2159.

PMID: 36419013 PMC: 9685883. DOI: 10.1186/s12889-022-14623-6.

Prevalence of sexually transmitted infections and associated risk behaviors in prisoners: A systematic review.

SeyedAlinaghi S, Pashaei Z, Rahimi E, Saeidi S, Mirzapour P, Noori T Health Sci Rep. 2022; 5(5):e819.

PMID: 36177400 PMC: 9478043. DOI: 10.1002/hsr2.819.

References

Looker K, Magaret A, May M, Turner K, Vickerman P, Gottlieb S . Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. PLoS One. 2015; 10(10):e0140765. PMC: 4624804. DOI: 10.1371/journal.pone.0140765. View

Fakoya I, Alvarez-Del Arco D, Woode-Owusu M, Monge S, Rivero-Montesdeoca Y, Delpech V . A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy. BMC Public Health. 2015; 15:561. PMC: 4472169. DOI: 10.1186/s12889-015-1852-9. View

Barnett R . Syphilis. Lancet. 2018; 391(10129):1471. DOI: 10.1016/S0140-6736(18)30833-X. View

Kazi A, Shah S, Jenkins C, Shepherd B, Vermund S . Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis. 2010; 14 Suppl 3:e60-6. PMC: 2905608. DOI: 10.1016/j.ijid.2009.11.012. View

Scott J, Chew K . Treatment optimization for HIV/HCV co-infected patients. Ther Adv Infect Dis. 2017; 4(1):18-36. PMC: 5360293. DOI: 10.1177/2049936116681279. View

Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Vonk Noordegraaf-Schouten M . Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area. Epidemiol Rev. 2018; 40(1):105-120. PMC: 5982719. DOI: 10.1093/epirev/mxy001. View

Hellard M, Aitken C . HIV in prison: what are the risks and what can be done?. Sex Health. 2005; 1(2):107-13. DOI: 10.1071/sh03018. View

Ndeffo-Mbah M, Vigliotti V, Skrip L, Dolan K, Galvani A . Dynamic Models of Infectious Disease Transmission in Prisons and the General Population. Epidemiol Rev. 2018; 40(1):40-57. PMC: 5982711. DOI: 10.1093/epirev/mxx014. View

Butler T, Donovan B, Taylor J, Cunningham A, Mindel A, Levy M . Herpes simplex virus type 2 in prisoners, New South Wales, Australia. Int J STD AIDS. 2000; 11(11):743-7. DOI: 10.1258/0956462001915174. View

10.

Rieder J, Gravier B, Bertrand D, Pasche C, Bodenmann P, Wolff H . [Health in prison: shared vulnerability between detainees and health professionals]. Rev Med Suisse. 2010; 6(257):1462-5. View

11.

Koelle D, Wald A . Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother. 2000; 45 Suppl T3:1-8. DOI: 10.1093/jac/45.suppl_4.1. View

12.

Nokhodian Z, Yazdani M, Yaran M, Shoaei P, Mirian M, Ataei B . Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran. Hepat Mon. 2012; 12(7):442-7. PMC: 3437455. DOI: 10.5812/hepatmon.6144. View

13.

Tan J, Joseph T, Saab S . Treating hepatitis C in the prison population is cost-saving. Hepatology. 2008; 48(5):1387-95. DOI: 10.1002/hep.22509. View

14.

Sarmati L, Babudieri S, Longo B, Starnini G, Carbonara S, Monarca R . Human herpesvirus 8 and human herpesvirus 2 infections in prison population. J Med Virol. 2006; 79(2):167-73. DOI: 10.1002/jmv.20774. View

15.

Wald A . Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes. 2004; 11 Suppl 3:130A-137A. View

16.

Kohler P, Schmidt A, Cavassini M, Furrer H, Calmy A, Battegay M . The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV. AIDS. 2015; 29(18):2509-15. DOI: 10.1097/QAD.0000000000000878. View

17.

Dolan K, Wirtz A, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner S . Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016; 388(10049):1089-1102. DOI: 10.1016/S0140-6736(16)30466-4. View

18.

Schiffer J, Corey L . New concepts in understanding genital herpes. Curr Infect Dis Rep. 2009; 11(6):457-64. PMC: 2804398. DOI: 10.1007/s11908-009-0066-7. View

19.

Tran N, Dubost C, Baggio S, Getaz L, Wolff H . Safer tattooing interventions in prisons: a systematic review and call to action. BMC Public Health. 2018; 18(1):1015. PMC: 6094923. DOI: 10.1186/s12889-018-5867-x. View

20.

Hammett T . HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health. 2006; 96(6):974-8. PMC: 1470637. DOI: 10.2105/AJPH.2005.066993. View